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a b s t r a c t
Insulin stimulates endothelial NO synthesis, at least in part mediated by phosphorylation and activation
of endothelial NO synthase at Ser1177 and Ser615 by Akt. We have previously demonstrated that insulin-
stimulated NO synthesis is inhibited under high culture glucose conditions, without altering Ca2+-stim-
ulated NO synthesis or insulin-stimulated phosphorylation of eNOS. This indicates that stimulation of
endothelial NO synthase phosphorylation may be required, yet not sufﬁcient, for insulin-stimulated nitric
oxide synthesis. In the current study we investigated the role of supply of the eNOS substrate, L-arginine
as a candidate parallel mechanism underlying insulin-stimulated NO synthesis in cultured human aortic
endothelial cells. Insulin rapidly stimulated L-arginine transport, an effect abrogated by incubation with
inhibitors of phosphatidylinositol-30-kinase or infection with adenoviruses expressing a dominant nega-
tive mutant Akt. Furthermore, supplementation of endothelial cells with extracellular L-arginine
enhanced insulin-stimulated NO synthesis, an effect reversed by co-incubation with the L-arginine trans-
port inhibitor, L-lysine. Basal L-arginine transport was signiﬁcantly increased under high glucose culture
conditions, yet insulin-stimulated L-arginine transport remained unaltered. The increase in L-arginine
transport elicited by high glucose was independent of the expression of the cationic amino acid trans-
porters, hCAT1 and hCAT2 and not associated with any changes in the activity of ERK1/2, Akt or protein
kinase C (PKC). We propose that rapid stimulation of L-arginine transport contributes to insulin-stimu-
lated NO synthesis in human endothelial cells, yet attenuation of this is unlikely to underlie the inhibition
of insulin-stimulated NO synthesis under high glucose conditions.
 2011 Elsevier Inc.
1. Introduction
Cardiovascular disease is the principal cause of morbidity and
mortality in patients with diabetes and is associated with endothe-
lial dysfunction, characterised by reduced nitric oxide (NO) bio-
availability, a key early mechanism in the progression of
atherosclerosis [1]. The molecular mechanisms that underlie the
association between diabetes, atherosclerosis and endothelial dys-
function are not, however, fully characterised. Insulin is a direct-
acting vasodilator in intact vessels [2,3] and stimulates NO produc-
tion in cultured endothelial cells [4,5]. We and others have re-
ported that insulin-stimulated NO synthesis is the result of
phosphatidylinositol-30-kinase (PI3 K)-mediated stimulation of
Akt (also known as protein kinase B (PKB)) and subsequent phos-
phorylation and activation of endothelial NO synthase (eNOS) at
Ser1177 and Ser615 [5–7].
We have previously demonstrated that culture of human aortic
endothelial cells (HAECs) in high glucose abrogated insulin-stimu-
lated NO synthesis, without altering Ca2+-stimulated NO synthesis,
indicating a speciﬁc downregulation of insulin signalling by high
glucose [5]. Furthermore, high glucose had no effect on insulin-
stimulated phosphorylation of eNOS at Ser1177 or Ser615 [5,7].
Similar studies in bovine aortic endothelial cells (BAECs) also
demonstrated an inhibition of insulin-stimulated NO synthesis by
culture in high glucose, with only a modest inhibition of insulin-
stimulated Ser1179 (bovine equivalent of Ser1177) phosphoryla-
tion [8]. We therefore reasoned that the dissociation of eNOS
phosphorylation and NO synthesis speciﬁc to insulin-stimulated
cells implies that stimulation of Akt and subsequent phosphoryla-
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lated NO synthesis in cells cultured in high glucose. Candidate
mechanisms that might underlie this eNOS phosphorylation-inde-
pendent mechanism, include altered supply of the eNOS substrate,
L-arginine [9], or altered regulation of eNOS activity by interactions
with proteins including heat shock protein (Hsp) 90 [10] and cave-
olin-1 [11].
Long-term (8 h) stimulation with insulin has previously been
demonstrated to increase the transport of L-arginine in cultured
human umbilical vein endothelial cells (HUVECs), in a manner sen-
sitive to the protein synthesis inhibitor, cycloheximide [9]. It has
also been reported that L-arginine transport can be rapidly in-
creased by various stimuli in HUVECs, indicating a capacity for reg-
ulation of transport independent of changes in transporter protein
expression [12,13]. In endothelial cells, L-arginine transport is
mediated by system y+, reﬂecting activity of the cationic amino
acid (CAT) transporters and system y+L, which reﬂects heterotri-
meric amino acid transporter activity [14]. The potential rapid ef-
fects of insulin on L-arginine transport, and thereby eNOS
substrate availability have yet to be characterised. In the current
study we investigated the role of L-arginine transport as a potential
mechanism underlying insulin-stimulated NO synthesis.2. Materials and methods
2.1. Materials
Cryopreserved HAECs were purchased from Promocell (Heidel-
berg, Germany) and large vessel endothelial cell media obtained
from TCS Cellworks (Botolph Claydon, Buckinghamshire, UK). L-
[2,3,4,5-3H] arginine was obtained from GE Healthcare (Little Chal-
font, Buckinghamshire, UK). L-lysine was obtained from Sigma
(Poole, Dorset, UK). PD98059, LY294002 and phorbol 12-myristate
13-acetate (PMA) were obtained from Merck (Nottingham, UK).
Rabbit anti-phospho-myristoylated alanine-rich protein kinase C
substrate (MARCKS) (Ser152/156), anti-phospho-extracellular sig-
nal regulated kinase (ERK)1/2 (Thr202/Tyr204); anti-ERK1/2;
anti-Akt and anti-phospho-Akt (Ser473) antibodies were from
New England Biolabs UK (Hitchin, UK). Rabbit anti-hCAT1 antibod-
ies were from Proteintech Europe (Manchester, UK). Rabbit anti-
hCAT2 antibodies were from Aviva Systems Biology (San Diego,
USA). Mouse anti-glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) antibodies were from Ambion (Huntingdon, UK). Replica-
tion-defective adenovirus vectors expressing mouse Akt were a
kind gift from Dr. Kenneth Walsh, Boston University School of
Medicine, Boston, USA and have been described previously [7].
All other reagents were from sources described previously [5,7].
2.2. Cell culture
HAECs were grown in large vessel endothelial cell medium con-
taining 5 mM glucose and passaged when at 80% conﬂuence as de-
scribed previously [5,7]. Cells were used for experiments between
passages 3 and 6 when 70–80% conﬂuent. Cells subjected to high
glucose were supplemented with glucose to obtain a ﬁnal concen-
tration of 25 mM or mannitol as an osmotic control as described
previously [5,7].
2.3. Preparation of adenoviruses and infection of HAECs
Adenoviruses expressing dominant negative Akt (Ad.Akt-DN),
constitutively active Akt (Ad.Akt-CA) or control adenoviruses
(Ad.control) were propagated and puriﬁed as described previously
[7]. HAECs were infected with 5 pfu/cell adenovirus in complete
medium and the cells cultured for 48 h prior to experimentation,with the ﬁnal 24 h in serum-free medium. Under these conditions
after infection with a green ﬂuorescent protein (GFP)-expressing
virus, the majority (>95%) of HAECs expressed GFP [7].
2.4. L-Arginine transport assay
Cells cultured in 6-well plates were preincubated in Krebs Ring-
er HEPES (KRH) buffer (119 mM NaCl, 4.75 mM KCl, 1.2 mM
MgSO4, 5 mM NaHCO3, 1.3 mM CaCl2, 20 mM HEPES pH7.4,
KH2PO4, 5 mM glucose) supplemented with a further 20 mM
(25 mM ﬁnal) glucose or mannitol at 37 C for 2 h and subse-
quently reagents (insulin, wortmannin, LY294002, PD98059 or bis-
indolylmaleimide I) added for the durations described. Plates were
transferred to preheated hot plates at 37 C for the assay. The
transport assay was initiated by the addition of 80 lM [3H]L-argi-
nine (0.19 MBq/ml) and after incubation for 1 min, transport was
stopped by plunging the plates into ice-cold PBS. Plates were air-
dried prior to lysis of the cells with 1% (v/v) Triton-X100. Cell-asso-
ciated 3H was measured by liquid scintillation counting and spe-
ciﬁc transport calculated by subtracting values obtained from
control plates incubated under identical conditions that had
10 mM L-lysine added 1 min prior to assay. L-Arginine transport
was normalised to total cellular protein within each well.
2.5. Evaluation of HAEC NO synthesis
HAECs cultured in 12-well plates were incubated in serum-free
medium overnight. Cells were preincubated for 1 h at 37 C in
0.5 ml/well KRH buffer. The medium was removed and replaced
with fresh KRH buffer (0.5 ml/well) in the presence of various con-
centrations of test substances. After incubation for various dura-
tions, aliquots of media were removed and analysed using a
Sievers 280A NO analyzer as described previously [5,7]. The appro-
priate control experiments were performed in the presence of the
eNOS inhibitor, L-NAME (0.5 mM). Data is presented as L-NAME-
sensitive NO synthesis.
2.6. Preparation of cell lysates, SDS PAGE and Western blotting
Cell lysates were prepared, proteins resolved by SDS–PAGE and
subjected to immunoblotting with the antibodies indicated as de-
scribed previously [5,7].
2.7. Statistics
Unless stated otherwise, results are expressed as the mean ± -
SEM. Statistically signiﬁcant differences were determined using a
two-tailed Student’s t test or ANOVA as appropriate, with
p < 0.05 deemed signiﬁcant.
3. Results
We ﬁrst addressed whether L-arginine supplementation affects
insulin-stimulated NO synthesis. In the presence of physiological
concentrations of extracellular L-arginine (80 lM), insulin-stimu-
lated NO synthesis was signiﬁcantly increased approximately
3.5-fold, an effect attenuated by the addition of 10 mM L-lysine,
an inhibitor of L-arginine transport (Fig. 1A).
Insulin rapidly (10 min) signiﬁcantly stimulated the transport
of L-arginine in HAECs 1.7 ± 0.2-fold (Fig. 1B). Preincubation with
the PI3 K inhibitor, wortmannin, completely and signiﬁcantly
inhibited insulin-stimulated L-arginine transport in HAECs
(Fig. 1B). Preincubation of HAECs with the structurally unrelated
PI3 K inhibitor, LY294002 gave quantitatively similar results to
those with wortmannin (Fig. 1B).
Fig. 1. Regulation of NO synthesis by L-arginine and L-arginine transport by insulin
in HAECs. (A) Basal and insulin-stimulated (1 lM, 5 min) NO synthesis was assessed
in HAECs pre-incubated in L-arginine (80 lM, 5 min) and/or L-lysine (10 mM,
5 min). Results are shown from six independent experiments. ⁄p < 0.05 relative to
value in absence of L-arginine, ⁄⁄p < 0.05 relative to value in absence of lysine. The
rate of L-arginine transport was assessed after (B) incubation of HAECs in the
presence or absence of insulin (1 lM, 10 min), wortmannin (100 nM, 45 min) or
LY294002 (10 lM, 30 min). (C) HAECs were infected with the indicated adenovi-
ruses for 48 h, prior to incubation in the presence or absence of insulin (1 lM,
10 min). Results are shown from (B) six or (C) three independent experiments.
⁄p < 0.01 relative to value in absence of insulin, $p < 0.05 relative to value in absence
of insulin. ⁄⁄p < 0.05 relative to value in absence of drug or control adenoviruses.
Fig. 2. The effect of high glucose on L-arginine transport in HAECs. The rate of L-
arginine transport was assessed (A) in HAECs after incubation in the glucose
concentrations indicated for 48 h and subsequent incubation in the presence or
absence of insulin (1 lM, 10 min) or (B) cultured in 5 mM or 25 mM glucose prior to
incubation in the presence or absence of wortmannin (wort; 100 nM, 40 min),
PD98059 (10 lM, 30 min) or Bisindolylmaleimide I (Bis I; 100 nM, 30 min). Results
are shown from (A) six or (B) ﬁve independent experiments. ⁄p < 0.005 relative to
value in absence of insulin, ⁄⁄p < 0.05 relative to value in presence of 5 mM glucose,
⁄⁄⁄p < 0.05 relative to value in vehicle.
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Akt, in insulin-stimulated L-arginine transport using Ad.Akt-DN or
Ad.Akt-CA. Infection of HAECs with Ad.Akt-DN signiﬁcantly re-
duced insulin-stimulated L-arginine transport by approximately
30% without reducing basal transport (Fig. 1C). In HAECs infected
with Ad.Akt-CA, basal L-arginine transport was signiﬁcantly in-
creased by 44% compared to control adenovirus infected HAECs,
yet insulin stimulation had no further signiﬁcant effect on L-argi-
nine transport (Fig. 1C).
To determine whether insulin-stimulated L-arginine transport
was impaired by culture in high glucose, we cultured cells in
5 mM or 25 mM glucose for 48 h and assessed basal and insulin-
stimulated L-arginine transport. High glucose signiﬁcantly in-
creased basal L-arginine transport 2.1 ± 0.4-fold (Fig. 2A). Culture
glucose concentration had no signiﬁcant effect on insulin-stimu-
lated L-arginine transport, yet insulin elicited a signiﬁcant 37%
reduction in L-arginine transport in HAECs cultured in high glucose
(Fig. 2A). The glucose-stimulated increase in basal L-arginine trans-
port was unaffected by preincubation with wortmannin, but was
abrogated by incubation with the MEK inhibitor, PD98059, or the
PKC inhibitor, bisindolylmaleimide I (Fig. 2B). High glucose hadno effect on basal or insulin-stimulated Akt Ser473 phosphoryla-
tion (Fig. 3). Neither high glucose nor insulin had any effect on
the phosphorylation of either MARCKS or ERK1/2, except for a
modest, non-signiﬁcant increase in ERK 1/2 phosphorylation in re-
sponse to the osmotic control, mannitol (Fig. 3). PMA elicited a
marked increase in the phosphorylation of both MARCKS and
ERK1/2 (Fig. 3). HAECs expressed both hCAT1 and hCAT2B, but
not hCAT2A, as assessed by semi-quantitative PCR (data not
shown). High glucose had no effect on the mRNA expression (data
not shown) or protein levels of hCAT1 or hCAT2 (Fig. 3).4. Discussion
The principal ﬁndings of this study are that insulin rapidly stim-
ulates L-arginine transport, an effect attenuated by the PI3 K inhib-
itor, wortmannin, or infection with adenoviruses expressing
dominant-negative mutant Akt. Furthermore, downregulation of
L-arginine transport attenuates insulin-stimulated NO synthesis.
The relationship between arginine supply and nitric oxide syn-
thesis is complex. Several reports have indicated that exogenous L-
arginine improves NO synthesis, yet the intracellular concentra-
tions of L-arginine exceed the KM of eNOS, such that additional L-
arginine should not further stimulate NO synthesis – the ‘arginine
paradox’ [15,16]. Previous studies in HUVECs demonstrated that
prolonged incubation with insulin stimulated L-arginine transport
in a manner sensitive to the protein synthesis inhibitor cyclohexi-
mide [9] and concomitantly increased mRNA expression of CAT
transporters, an effect abrogated by inhibitors of PI3K, PKC and
ERK 1/2 [17]. The rapid stimulation by insulin reported in this
study, however, is unlikely to reﬂect de novo synthesis of trans-
porter proteins and was, at least in part, mediated by Akt activa-
tion, suggesting insulin-stimulated Akt activity directly
phosphorylates transporters or stimulates transporter activity
through a less direct mechanism. The observation that basal and
insulin-stimulated HAEC NO synthesis was increased by extracel-
Fig. 3. The effect of high glucose on ERK, Akt and PKC signalling in HAECs. Conﬂuent HAECs were incubated in 5 mM glucose, 5 mM glucose + 20 mMmannitol (M) or 25 mM
glucose (G) for 48 h and subsequently incubated in the presence or absence of insulin or PMA (1 lM, 10 min). Lysates were prepared and subjected to immunoblotting with
the antibodies indicated. (A) and (C) Representative blots from six (ERK1/2, Akt), three (MARCKS) or ﬁve (hCAT1, hCAT2) independent experiments are shown. (B)
Phosphorylation was quantiﬁed relative to total expression (GAPDH in the case of phospho-MARCKS) in each lysate. (D) Expression was quantiﬁed relative to GAPDH in each
lysate.
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tribute to insulin-stimulated NO synthesis. In support of this
hypothesis, the effect was abrogated by co-incubation (for 5 min)
with high concentrations of L-lysine, used in the L-arginine trans-
port assay to inhibit transport. A similar effect has been reported
in A23187-stimulated EA.hy926 cells by L-lysine [18].
Culture in high glucose concentrations markedly increased L-
arginine transport in HAECs, in agreement with previous studies
in HUVECs [9]. PCR experiments demonstrated that HAECs ex-
pressed mRNA for hCAT1 and hCAT2B, but not hCAT2A, as has pre-
viously been reported in HUVECs [19]. One previous study in
HUVECs has reported that incubation in high glucose for 6 h mark-
edly increased hCAT1 mRNA levels [20], yet the level of hCAT1 pro-
tein was not reported. In the current study, hCAT1 and hCAT2
protein levels in HAECs were unaffected by glucose culture concen-
tration, indicating that the glucose-stimulated change in arginine
transport is likely to reﬂect a change in activity, rather than expres-
sion of the hCAT isoforms. Furthermore, the effect of high glucose
was attenuated by inhibitors of either ERK1/2 or PKC but was
insensitive to wortmannin, suggesting that both PKC and ERK1/2
activity contribute to increased L-arginine transport. In the current
study, PKC activity was not altered by glucose and/or insulin as as-
sessed by phospho-MARCKS immunoblots. In addition, no change
in ERK 1/2 phosphorylation or expression was observed in re-
sponse to glucose and/or insulin. Incubation with high glucosehas been reported to rapidly (5 min–6 h) stimulate PKC activity
in HAECs and HUVECs and ERK phosphorylation in HUVECs [20–
22]. The different effects of high glucose on PKC and ERK1/2 phos-
phorylation compared to these more short-term studies are likely
to reﬂect the very different timescales of stimulation with high
glucose. Indeed, in HAECs, prolonged high glucose culture condi-
tions were reported to have no effect on ERK1/2 phosphorylation
[23], in agreement with the current study.
Taken together, these data suggest that insulin rapidly stimu-
lates L-arginine transport via a PI3K-Akt-dependent mechanism,
which contributes to insulin-stimulated NO synthesis. High glu-
cose conditions also increase L-arginine transport in an ERK1/2
and PKC inhibitor-sensitive manner. As we detected no apparent
activation of either of these kinases under high glucose conditions,
it seems likely that basal ERK1/2 and PKC activity are required for
the response to high glucose, rather than activation itself. It is clear,
therefore, that there is no simple quantitative relationship be-
tween arginine transport and NO synthesis, as insulin stimulates
NO synthesis and L-arginine transport, but inhibits high glucose
stimulated L-arginine transport, in agreement with previous stud-
ies in HUVECs [9]. Indeed, insulin-stimulated HAECs cultured in
normal or high glucose conditions had very similar rates of L-argi-
nine transport, as described previously [9], yet elicit different rates
of NO synthesis [5]. It therefore is likely that although L-arginine
transport contributes to insulin-stimulated NO synthesis in normal
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underlie the impaired insulin-stimulated NO synthesis observed
in HAECs cultured in high glucose [5].
In conclusion, we propose that while increased supply of L-argi-
nine contributes to insulin-stimulated NO synthesis, reduced insu-
lin-stimulated L-arginine transport does not explain the speciﬁc
reduction in insulin-stimulated NO synthesis we have previously
demonstrated under high glucose conditions. Further work is nec-
essary to identify the mechanisms impaired by high glucose cul-
ture conditions. Such studies should include an analysis of the
regulation of subcellular localisation of eNOS and association of
eNOS with caveolin-1 and/or Hsp90.
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